Yaron Ilan
Researcher Next ID · RN-042270
Researcher · Immunology and Microbiology
Jerusalem, Israel
- Works count
- 420
- Citation count
- 10,966
- H-index
- 58
- i10-index
- 240
Research interests
Publications
Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases
European Journal of Human Genetics · 2021 · 10.1038/s41431-021-00928-4
Microtubules: From understanding their dynamics to using them as potential therapeutic targets
Journal of Cellular Physiology · 2018 · 10.1002/jcp.27978
Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis
World Journal of Gastroenterology · 2012 · 10.3748/wjg.v18.i21.2609
Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice
Proceedings of the National Academy of Sciences · 2010 · https://doi.org/10.1073/pnas.0908771107
Adoptive transfer of regulatory NKT lymphocytes ameliorates non‐alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping
The Journal of Pathology · 2006 · 10.1002/path.1950
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC
Journal of Hepatology · 2006 · https://doi.org/10.1016/j.jhep.2005.12.025
Treatment of Chronic Hepatitis C Virus Infection via Antioxidants
Journal of Clinical Gastroenterology · 2005 · 10.1097/01.mcg.0000174023.73472.29
Prognosis of Symptomatic Versus Asymptomatic Autoimmune Hepatitis
Journal of Clinical Gastroenterology · 2002 · 10.1097/00004836-200207000-00016
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers
Blood · 2002 · 10.1182/blood.v100.2.391
Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat
Hepatology · 1997 · 10.1002/hep.510260422
Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.
Journal of Clinical Investigation · 1997 · 10.1172/jci119238
Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression
Proceedings of the National Academy of Sciences · 1997 · 10.1073/pnas.94.6.2587
Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats.
Journal of Clinical Investigation · 1996 · 10.1172/jci119085
Long Term Correction of Bilirubin-UDP-glucuronosyltransferase Deficiency in Gunn Rats by Administration of a Recombinant Adenovirus during the Neonatal Period
Journal of Biological Chemistry · 1996 · 10.1074/jbc.271.43.26536
Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines
Vaccine · 1994 · 10.1016/0264-410x(94)90155-4
Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor
Gastroenterology · 1993 · 10.1016/0016-5085(93)90664-x
Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation
Hepatology · 1993 · 10.1002/hep.1840180204
Current projects
No projects listed.